Pulsify Medical is a Leuven, Belgium-based digital medical technology company focused on the development of wearable ultrasound patches.
A a spin-off of imec and KU Leuven, Pulsify Medical builds on the unique and IP-protected technology of both research institutes: on the one hand, imec’s unique flexible ultrasound transducer technology and design know-how for transducers, thin film transistors and system architecture, and on the other hand, KU Leuven’s world-class expertise in cardiac ultrasound imaging, the company said in a press release.
“We envision a breakthrough in ultrasound-based medical imaging,” said Iwan van Vijfeijken, CEO of Pulsify Medical. “Accurate and non-invasive cardiac monitoring will change current practice at intensive care units. In Europe, approximately 70 million people suffer from cardiovascular diseases of which each year 15% are hospitalized. Our technology will follow patients’ basic health parameters all over the hospital and at home, without requiring the intervention of specially trained individuals to obtain and interpret results. Changes in the functioning of the heart will be signaled, allowing doctors to intervene.”
Pulsify Medical recently raised € 2.6 million euros in seed funding. Imec.xpand and KU Leuven led the investment together and were joined by University Hospitals Leuven. Imec.xpand is an early stage and growth fund with a game-changing approach to turn hardware driven nanotechnology innovation into successful global companies.
Xavier Rottenberg, Scientific Director at imec described ultrasound imaging as a safe technique to produce images with exquisite details revealing critical information on a patient’s health. “However, it isn’t yet widely available as a monitoring tool in intensive care units, let alone in ambulatory settings. Pulsify Medical will change this. We will improve life quality, by preventing adverse events and allowing shorter hospital stays, and we will even save lives,” Mr. Rottenberg said.
Professor Jan D’hooge, KU Leuven and University Hospitals Leuven, concluded: “Pulsify Medical will integrate and mature state-of-the-art technologies from two world-class Leuven-based research institutes. The technology platform provided by KU Leuven is based on over ten years of research and has extensively been tested at University Hospitals Leuven. Pulsify Medical’s product will open up new application domains for ultrasound that go well beyond cardiac diagnostics.”